Ovarian cancer affects anyone with ovaries, most commonly women who are older than 50, the NHS explains - here are the ...

Researchers at the University of Pittsburgh have found special high-risk cells in the fallopian tubes that may trigger ...

AbbVie (NYSE: ABBV) today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE® (mirvetuximab soravtansine-gynx) in women with folate ...

The late-breaking oral presentation at SGO 2025 highlights consistent response rates observed in patients across all levels of FRα expression of 25% or greater -SOUTH SAN FRANCISCO, Calif., March 15, ...

A new type of antibody which stimulates the immune system to target cancer cells slows tumour growth, according to new research.

A Buckinghamshire teacher has issued a stark warning to women who suffer a common ailment - after the problem turned out to ...

Ovarian cancer is the deadliest form of gynecologic cancer, taking the lives of more than 13,000 women in the U.S. each year.

To fake everything, she staged her own photos showing she appeared for chemotherapy. Meanwhile, the report mentioned, she ...

New research reveals a gap in menopause support for breast cancer survivors and a lack of involvement in decision-making ...

Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with ...